The BioPharm Brief: Metabolic Phase III Progress, HER2 Oncology Momentum, and US Manufacturing Expansion Drive Industry Scale
Welcome to The BioPharm Brief, your daily snapshot of the latest developments shaping biopharmaceutical research, regulatory progress, and global manufacturing strategy. Today’s update highlights advances in metabolic disease, oncology regulatory momentum, and continued investment in US-based drug production infrastructure.
2m
•
Apr 30